Since KDM6A connects KMT2D and RB1 mutations we hypothesize that there is a biological pathway that unites the impact of these three mutated genes and is important for the biologic fitness of bladder cancer cells. This evidence concerns the gene RB1 and urinary bladder carcinoma.